Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG lifted its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 28.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,199 shares of the company’s stock after purchasing an additional 931 shares during the period. Deutsche Bank AG’s holdings in Azenta were worth $210,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Corton Capital Inc. purchased a new position in shares of Azenta during the fourth quarter worth about $295,000. Captrust Financial Advisors grew its holdings in shares of Azenta by 22.1% during the fourth quarter. Captrust Financial Advisors now owns 11,179 shares of the company’s stock worth $559,000 after buying an additional 2,026 shares during the last quarter. Caxton Associates LP purchased a new position in shares of Azenta during the fourth quarter worth about $1,598,000. BNP Paribas Financial Markets grew its holdings in shares of Azenta by 86.1% during the fourth quarter. BNP Paribas Financial Markets now owns 58,104 shares of the company’s stock worth $2,905,000 after buying an additional 26,877 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in shares of Azenta by 59.4% during the fourth quarter. Ameriprise Financial Inc. now owns 247,402 shares of the company’s stock worth $12,370,000 after buying an additional 92,146 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Azenta Trading Down 0.3%

AZTA stock opened at $26.63 on Tuesday. The firm has a 50 day moving average of $27.82 and a 200-day moving average of $40.22. Azenta, Inc. has a 12-month low of $23.91 and a 12-month high of $63.58. The company has a market cap of $1.22 billion, a price-to-earnings ratio of -8.94 and a beta of 1.64.

Azenta (NASDAQ:AZTA) last posted its earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. The company’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.06 earnings per share. Sell-side analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on AZTA shares. Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. Needham & Company LLC lowered their price target on Azenta from $59.00 to $40.00 and set a “buy” rating on the stock in a report on Wednesday, May 7th. Finally, TD Cowen raised Azenta to a “hold” rating in a report on Thursday, February 27th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.